Takenori Yamaguchi Selected Research

Takenori Yamaguchi Research Topics

Disease

58	Stroke (Strokes) 01/2024 - 09/2002
31	Ischemic Stroke 10/2023 - 09/2002
29	Atrial Fibrillation 02/2024 - 01/2005
28	Hemorrhage 02/2024 - 02/2006
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 01/2007
7	Cerebral Infarction 06/2016 - 01/2007
6	Embolic Stroke 01/2020 - 09/2002
4	Heart Failure 01/2024 - 08/2023
4	Embolism (Embolus) 01/2024 - 06/2016
4	Infarction (Infarctions) 06/2016 - 09/2002
4	Cerebral Hemorrhage 01/2014 - 02/2003
3	Diabetes Mellitus 02/2024 - 01/2005
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2023 - 01/2008
3	Pathologic Constriction (Stenosis) 01/2023 - 02/2015
3	Lacunar Stroke 01/2023 - 01/2008
3	Hemorrhagic Stroke 01/2020 - 01/2014
3	Hypertension (High Blood Pressure) 02/2015 - 01/2007
2	Myocardial Infarction 08/2023 - 10/2021
2	Body Weight (Weight, Body) 11/2022 - 11/2020
2	Transient Ischemic Attack 01/2020 - 06/2016
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2010 - 03/2010
2	Brain Infarction 03/2004 - 01/2003
1	Dementia (Dementias) 11/2023
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Frailty 07/2022
1	Neoplasms (Cancer) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Masked Hypertension 01/2021
1	Chronic Renal Insufficiency 10/2020
1	Acute Coronary Syndrome 01/2020
1	Atherosclerosis 09/2015
1	Brain Edema (Cerebral Edema) 09/2015
1	Hyperlipidemias (Hyperlipidemia) 02/2014
1	Headache (Headaches) 10/2010
1	Dizziness (Lightheadedness) 10/2010
1	Tachycardia (Tachyarrhythmias) 10/2010
1	Leukoaraiosis 12/2009
1	Albuminuria 02/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2009
1	Pica (Geophagia) 01/2007
1	Atrophy 03/2004
1	Hematoma 02/2003
1	Heart Diseases (Heart Disease) 09/2002

Drug/Important Bio-Agent (IBA)

28	AnticoagulantsIBA 02/2024 - 09/2002
19	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 02/2003
12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2023 - 02/2006
11	Cilostazol (Pletal)FDA LinkGeneric 06/2023 - 01/2008
10	Clopidogrel (Plavix)FDA Link 06/2023 - 01/2008
9	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2018 - 01/2004
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2024 - 01/2008
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2023 - 02/2015
4	EdaravoneIBA 05/2018 - 08/2013
3	CreatinineIBA 11/2023 - 11/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015 - 11/2011
2	Factor Xa InhibitorsIBA 01/2021 - 01/2012
2	Pravastatin (Pravachol)FDA LinkGeneric 09/2015 - 02/2014
2	CholesterolIBA 02/2014 - 02/2009
2	argatroban (MPQA)FDA Link 12/2013 - 08/2013
2	Perindopril FDA LinkGeneric 02/2010 - 03/2004
2	Ticlopidine (Ticlid)FDA LinkGeneric 06/2009 - 01/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 08/2023
1	fibrin fragment D (D-dimer)IBA 08/2023
1	Proton Pump InhibitorsIBA 01/2020
1	Purinergic P2Y Receptor AntagonistsIBA 01/2020
1	N- (5- (2- bromobenzyl)thiazole- 2- yl)benzofuran- 2- carboxamideIBA 01/2020
1	Prasugrel Hydrochloride FDA Link 01/2020
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 04/2017
1	RivaroxabanIBA 06/2016
1	Desmodus rotundus salivary plasminogen activator alpha 1IBA 09/2015
1	edoxabanIBA 01/2012
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2011
1	Dipyridamole Drug Combination Aspirin FDA LinkGeneric 01/2011
1	Antihypertensive Agents (Antihypertensives)IBA 02/2010
1	Indapamide FDA LinkGeneric 02/2010
1	DiureticsIBA 02/2010
1	Receptor for Advanced Glycation End ProductsIBA 12/2009
1	sarpogrelateIBA 06/2008
1	FibrinIBA 06/2008
1	nilvadipine (Escor)IBA 01/2007
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2005
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2004

Therapy/Procedure

26	Therapeutics 01/2024 - 09/2002
11	Secondary Prevention 01/2023 - 05/2003
4	Catheter Ablation 11/2023 - 11/2020
3	Polypharmacy 01/2024 - 12/2022
1	Percutaneous Coronary Intervention 01/2020
1	Aftercare (After-Treatment) 03/2010
1	Critical Care (Surgical Intensive Care) 01/2007
1	Thrombolytic Therapy 01/2005
1	Home Nursing (Nursing, Home) 01/2005
1	Length of Stay 01/2004
1	Plasmapheresis 01/2003